Ajinomoto (2802) Investor update summary
Event summary combining transcript, slides, and related documents.
Investor update summary
9 Apr, 2026Governance and board effectiveness
Revised group code of conduct (AGP) and policies to address evolving environmental, social, and stakeholder requirements, implemented April 1st.
Governance structure clarified, emphasizing compliance, transparent relationships with politicians and governments, and prioritizing stakeholder responsibilities.
Established Group Compliance Committee to oversee global compliance, AGP implementation, hotline operations, and regional compliance structures.
Board effectiveness survey ongoing, focusing on direction-setting, risk support, operational supervision, and regular evaluation of internal controls.
Plans to align board members on priorities, evolve board structure and agenda in 2026, and standardize processes to support growth.
Executive management, succession, and compensation
Succession plan executed with new president and ongoing development of a medium- to long-term growth strategy and 2030 roadmap.
Executive compensation under review to strengthen linkage with performance, shareholder value, and ambitious goals, with more weight on medium-term incentives and TSR.
Feedback from investors and executives shaped compensation revisions, aiming for transparency, market competitiveness, and value-driven incentives.
Short-term incentives now reward exceptional performance; medium-term incentives emphasize TSR, with unified calculation formulas and expanded eligibility for stock-based incentives.
New system includes personalized communication, ongoing feedback sessions, and consideration to grant shares to overseas officers and adjust incentive curves.
Audit and risk management
Recognized by FSA for best practices in audit disclosure and hybrid audit approach combining internal and management audits.
Audit committee conducts site visits and interviews to ensure psychological safety and gather candid feedback.
Hybrid audits cover both domestic and overseas subsidiaries, focusing on operational and governance aspects.
Focus on business risks, audit, and revision of group policies.
Latest events from Ajinomoto
- AI-driven growth boosts ABF/ABF™ demand, margins, and capacity through innovation and investment.2802
Investor update3 Jul 2026 - Record sales and profit growth led to upward forecasts and increased shareholder returns.2802
Q2 20251 Jul 2026 - Record sales and profit highs, with raised full-year profit outlook and strong segment momentum.2802
Q3 202630 Jun 2026 - Global leader in amino acid science targets growth, health impact, and major sustainability gains.2802
Investor presentation30 Jun 2026 - Record profit and sales growth achieved, with further gains targeted amid managed global risks.2802
Q4 202613 May 2026 - Integrated sustainability and agri-food innovation drive growth and aim to double key solution sales by 2030.2802
Investor Day 20266 May 2026 - Record Q1 sales and profit, but net profit fell 12% due to a temporary tax impact.2802
Q1 20252 Feb 2026 - Record sales and profit growth led by overseas, healthcare, and currency gains amid cost pressures.2802
Q3 20259 Jan 2026 - Profit attributable to owners rose 2% as H1 results were flat, with strong H2 recovery expected.2802
Q2 202610 Dec 2025